(S)-tert-Butyl 3-formylpyrrolidine-1-carboxylate, 95.0%, 1g

(R)-3-(1-(2,6-Dichloro-3-fluorophenyl)ethoxy)pyridin-2-amine, 95.0%, 5g

Anti-Chondroitin Sulfate D Monoclonal Antibody (MO-225)1vial

2,3-dihydro-1,4-benzodioxine-6-carbaldehyde oxime, 98.0%, 5g

(1?,8?,9?)-Bicyclo[6.1.0]non-4-yn-9-ylmethanol, 90.0%, 5g

2,2,14,14-Tetramethyl-8-oxopentadecanedioic acid diethyl ester, 97%, 5g

4-Methoxy-2,5-dimethylfuran-3(2H)-one, 95.0%, 500g

2-(4-Bromophenyl)-5-(1-naphthyl)-1,3,4-oxadiazole, 97%, 1g

tert-Butyl 7-amino-5-azaspiro[2.5]octane-5-carboxylate, 98%, 100mg

(4-Butoxy-2,3-difluorophenyl)boronic acid, 95.0%, 10g

N1-(FURAN-2-YLMETHYL)-N2-(2-METHYLNAPHTHALEN-1-YL)OXALAMIDE, 95%, 5g

2-((6-Chloro-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile, 95.0%, 25g

5-Chloro-1H-indazole-3-carbonitrile, 95.0%, 250mg